Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury

Display Omitted

Gespeichert in:

Autor*in:	Su, Qiang [verfasserIn] Lv, Xiangwei Sun, Yuhan Yang, Huafeng Ye, Ziliang Li, Lang

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2018

Schlagwörter:	Coronary microembolization HMGA1 Inflammation Myocardial injury

Umfang:	8

Übergeordnetes Werk:	Enthalten in: A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a - Liao, Gary ELSEVIER, 2020, Amsterdam [u.a.]
Übergeordnetes Werk:	volume:105 ; year:2018 ; pages:1164-1171 ; extent:8

Links:	Volltext

DOI / URN:	10.1016/j.biopha.2018.06.098

Katalog-ID:	ELV04366668X

Internformat


LEADER	01000caa a22002652 4500
001	ELV04366668X
003	DE-627
005	20230624104622.0
007	cr uuu---uuuuu
008	180726s2018 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1016/j.biopha.2018.06.098 \|2 doi
028	5	2	\|a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001593.pica
035			\|a (DE-627)ELV04366668X
035			\|a (ELSEVIER)S0753-3322(18)32886-5
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 610 \|q VZ
084			\|a 44.86 \|2 bkl
100	1		\|a Su, Qiang \|e verfasserin \|4 aut
245	1	0	\|a Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury
264		1	\|c 2018
300			\|a 8
336			\|a nicht spezifiziert \|b zzz \|2 rdacontent
337			\|a nicht spezifiziert \|b z \|2 rdamedia
338			\|a nicht spezifiziert \|b zu \|2 rdacarrier
520			\|a Display Omitted
650		7	\|a Coronary microembolization \|2 Elsevier
650		7	\|a HMGA1 \|2 Elsevier
650		7	\|a Inflammation \|2 Elsevier
650		7	\|a Myocardial injury \|2 Elsevier
700	1		\|a Lv, Xiangwei \|4 oth
700	1		\|a Sun, Yuhan \|4 oth
700	1		\|a Yang, Huafeng \|4 oth
700	1		\|a Ye, Ziliang \|4 oth
700	1		\|a Li, Lang \|4 oth
773	0	8	\|i Enthalten in \|n Elsevier Science \|a Liao, Gary ELSEVIER \|t A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a \|d 2020 \|g Amsterdam [u.a.] \|w (DE-627)ELV004620771
773	1	8	\|g volume:105 \|g year:2018 \|g pages:1164-1171 \|g extent:8
856	4	0	\|u https://doi.org/10.1016/j.biopha.2018.06.098 \|3 Volltext
912			\|a GBV_USEFLAG_U
912			\|a GBV_ELV
912			\|a SYSFLAG_U
912			\|a SSG-OLC-PHA
936	b	k	\|a 44.86 \|j Hämatologie \|q VZ
951			\|a AR
952			\|d 105 \|j 2018 \|h 1164-1171 \|g 8

Indexfelder

author_variant	q s qs
matchkey_str	suqianglvxiangweisunyuhanyanghuafengyezi:2018----:oefihoiiyruanceratrapbinlnicrnrmcomoi
hierarchy_sort_str	2018
bklnumber	44.86
publishDate	2018
allfields	10.1016/j.biopha.2018.06.098 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001593.pica (DE-627)ELV04366668X (ELSEVIER)S0753-3322(18)32886-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Su, Qiang verfasserin aut Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury 2018 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Coronary microembolization Elsevier HMGA1 Elsevier Inflammation Elsevier Myocardial injury Elsevier Lv, Xiangwei oth Sun, Yuhan oth Yang, Huafeng oth Ye, Ziliang oth Li, Lang oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:105 year:2018 pages:1164-1171 extent:8 https://doi.org/10.1016/j.biopha.2018.06.098 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 105 2018 1164-1171 8
spelling	10.1016/j.biopha.2018.06.098 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001593.pica (DE-627)ELV04366668X (ELSEVIER)S0753-3322(18)32886-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Su, Qiang verfasserin aut Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury 2018 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Coronary microembolization Elsevier HMGA1 Elsevier Inflammation Elsevier Myocardial injury Elsevier Lv, Xiangwei oth Sun, Yuhan oth Yang, Huafeng oth Ye, Ziliang oth Li, Lang oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:105 year:2018 pages:1164-1171 extent:8 https://doi.org/10.1016/j.biopha.2018.06.098 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 105 2018 1164-1171 8
allfields_unstemmed	10.1016/j.biopha.2018.06.098 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001593.pica (DE-627)ELV04366668X (ELSEVIER)S0753-3322(18)32886-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Su, Qiang verfasserin aut Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury 2018 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Coronary microembolization Elsevier HMGA1 Elsevier Inflammation Elsevier Myocardial injury Elsevier Lv, Xiangwei oth Sun, Yuhan oth Yang, Huafeng oth Ye, Ziliang oth Li, Lang oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:105 year:2018 pages:1164-1171 extent:8 https://doi.org/10.1016/j.biopha.2018.06.098 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 105 2018 1164-1171 8
allfieldsGer	10.1016/j.biopha.2018.06.098 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001593.pica (DE-627)ELV04366668X (ELSEVIER)S0753-3322(18)32886-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Su, Qiang verfasserin aut Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury 2018 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Coronary microembolization Elsevier HMGA1 Elsevier Inflammation Elsevier Myocardial injury Elsevier Lv, Xiangwei oth Sun, Yuhan oth Yang, Huafeng oth Ye, Ziliang oth Li, Lang oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:105 year:2018 pages:1164-1171 extent:8 https://doi.org/10.1016/j.biopha.2018.06.098 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 105 2018 1164-1171 8
allfieldsSound	10.1016/j.biopha.2018.06.098 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001593.pica (DE-627)ELV04366668X (ELSEVIER)S0753-3322(18)32886-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Su, Qiang verfasserin aut Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury 2018 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Coronary microembolization Elsevier HMGA1 Elsevier Inflammation Elsevier Myocardial injury Elsevier Lv, Xiangwei oth Sun, Yuhan oth Yang, Huafeng oth Ye, Ziliang oth Li, Lang oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:105 year:2018 pages:1164-1171 extent:8 https://doi.org/10.1016/j.biopha.2018.06.098 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 105 2018 1164-1171 8
language	English
source	Enthalten in A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Amsterdam [u.a.] volume:105 year:2018 pages:1164-1171 extent:8
sourceStr	Enthalten in A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Amsterdam [u.a.] volume:105 year:2018 pages:1164-1171 extent:8
format_phy_str_mv	Article
bklname	Hämatologie
institution	findex.gbv.de
topic_facet	Coronary microembolization HMGA1 Inflammation Myocardial injury
dewey-raw	610
isfreeaccess_bool	false
container_title	A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a
authorswithroles_txt_mv	Su, Qiang @@aut@@ Lv, Xiangwei @@oth@@ Sun, Yuhan @@oth@@ Yang, Huafeng @@oth@@ Ye, Ziliang @@oth@@ Li, Lang @@oth@@
publishDateDaySort_date	2018-01-01T00:00:00Z
hierarchy_top_id	ELV004620771
dewey-sort	3610
id	ELV04366668X
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04366668X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624104622.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.biopha.2018.06.098</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001593.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04366668X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0753-3322(18)32886-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.86</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Su, Qiang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Coronary microembolization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HMGA1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Myocardial injury</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lv, Xiangwei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sun, Yuhan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Huafeng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ye, Ziliang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Lang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Liao, Gary ELSEVIER</subfield><subfield code="t">A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV004620771</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:105</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:1164-1171</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.biopha.2018.06.098</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.86</subfield><subfield code="j">Hämatologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">105</subfield><subfield code="j">2018</subfield><subfield code="h">1164-1171</subfield><subfield code="g">8</subfield></datafield></record></collection>
author	Su, Qiang
spellingShingle	Su, Qiang ddc 610 bkl 44.86 Elsevier Coronary microembolization Elsevier HMGA1 Elsevier Inflammation Elsevier Myocardial injury Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury
authorStr	Su, Qiang
ppnlink_with_tag_str_mv	@@773@@(DE-627)ELV004620771
format	electronic Article
dewey-ones	610 - Medicine & health
delete_txt_mv	keep
author_role	aut
collection	elsevier
remote_str	true
illustrated	Not Illustrated
topic_title	610 VZ 44.86 bkl Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury Coronary microembolization Elsevier HMGA1 Elsevier Inflammation Elsevier Myocardial injury Elsevier
topic	ddc 610 bkl 44.86 Elsevier Coronary microembolization Elsevier HMGA1 Elsevier Inflammation Elsevier Myocardial injury
topic_unstemmed	ddc 610 bkl 44.86 Elsevier Coronary microembolization Elsevier HMGA1 Elsevier Inflammation Elsevier Myocardial injury
topic_browse	ddc 610 bkl 44.86 Elsevier Coronary microembolization Elsevier HMGA1 Elsevier Inflammation Elsevier Myocardial injury
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	zu
author2_variant	x l xl y s ys h y hy z y zy l l ll
hierarchy_parent_title	A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a
hierarchy_parent_id	ELV004620771
dewey-tens	610 - Medicine & health
hierarchy_top_title	A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)ELV004620771
title	Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury
ctrlnum	(DE-627)ELV04366668X (ELSEVIER)S0753-3322(18)32886-5
title_full	Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury
author_sort	Su, Qiang
journal	A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a
journalStr	A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a
lang_code	eng
isOA_bool	false
dewey-hundreds	600 - Technology
recordtype	marc
publishDateSort	2018
contenttype_str_mv	zzz
container_start_page	1164
author_browse	Su, Qiang
container_volume	105
physical	8
class	610 VZ 44.86 bkl
format_se	Elektronische Aufsätze
author-letter	Su, Qiang
doi_str_mv	10.1016/j.biopha.2018.06.098
dewey-full	610
title_sort	role of high mobility group a1/nuclear factor-kappa b signaling in coronary microembolization-induced myocardial injury
title_auth	Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury
abstract	Display Omitted
abstractGer	Display Omitted
abstract_unstemmed	Display Omitted
collection_details	GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA
title_short	Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury
url	https://doi.org/10.1016/j.biopha.2018.06.098
remote_bool	true
author2	Lv, Xiangwei Sun, Yuhan Yang, Huafeng Ye, Ziliang Li, Lang
author2Str	Lv, Xiangwei Sun, Yuhan Yang, Huafeng Ye, Ziliang Li, Lang
ppnlink	ELV004620771
mediatype_str_mv	z
isOA_txt	false
hochschulschrift_bool	false
author2_role	oth oth oth oth oth
doi_str	10.1016/j.biopha.2018.06.098
up_date	2024-07-06T19:25:28.819Z
_version_	1803858926706360320
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04366668X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624104622.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.biopha.2018.06.098</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001593.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04366668X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0753-3322(18)32886-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.86</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Su, Qiang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Coronary microembolization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HMGA1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Myocardial injury</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lv, Xiangwei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sun, Yuhan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Huafeng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ye, Ziliang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Lang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Liao, Gary ELSEVIER</subfield><subfield code="t">A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV004620771</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:105</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:1164-1171</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.biopha.2018.06.098</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.86</subfield><subfield code="j">Hämatologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">105</subfield><subfield code="j">2018</subfield><subfield code="h">1164-1171</subfield><subfield code="g">8</subfield></datafield></record></collection>
score	7.401045

Nicht das Richtige dabei?

Schreiben Sie uns!

Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?